Kim Jun Ki, Byun Mi Ran, Maeng Chi Hoon, Kim Yi Rang, Choi Jin Woo
Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Korea.
Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea.
Cancers (Basel). 2020 Jan 14;12(1):203. doi: 10.3390/cancers12010203.
Targeting cancer stem cells (CSCs) without damaging normal stem cells could contribute to the development of novel radical cancer therapies. Cells expressing leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) constitute a cancer-causing population in the colon; therefore, targeting of Lgr5+ cells is expected to provide an opportunity to mitigate colon cancer. However, the expression of Lgr5 in normal stem cells makes it difficult to prove the efficacy of therapies targeted exclusively at Lgr5+ cancer cells. We used a modified photodynamic therapy technique involving cellular radiative transfer between green fluorescent protein (GFP)-expressing cells and a rose bengal photosensitizer. After treatment, tumors containing GFP-Lgr5+ cells were observed to be significantly suppressed or retarded with little effect on GFP-Lgr5+ stem cells at the crypt bottom. Lgr5+ CSCs were specifically eradicated in situ, when localized based on the depth from the colon lumen, revealing the potential preventive efficacy of Lgr5-targeted therapy on tumor growth. This study supports the idea that Lgr5+ cells localized near the colon luminal surface are central to colorectal cancer. With further development, the targeting of localized Lgr5+ cancer stem cells, which this study demonstrates in concept, may be feasible for prevention of colon cancer in high-risk populations.
在不损害正常干细胞的情况下靶向癌症干细胞(CSCs)有助于开发新型的根治性癌症疗法。表达富含亮氨酸重复序列的G蛋白偶联受体5(Lgr5)的细胞构成了结肠中的致癌群体;因此,靶向Lgr5 +细胞有望为减轻结肠癌提供机会。然而,Lgr5在正常干细胞中的表达使得难以证明专门针对Lgr5 +癌细胞的疗法的疗效。我们使用了一种改良的光动力疗法技术,该技术涉及表达绿色荧光蛋白(GFP)的细胞与孟加拉玫瑰红光敏剂之间的细胞辐射转移。治疗后,观察到含有GFP-Lgr5 +细胞的肿瘤被显著抑制或生长迟缓,而对隐窝底部的GFP-Lgr5 +干细胞影响很小。当根据距结肠腔的深度定位时,Lgr5 + CSCs在原位被特异性根除,这揭示了Lgr5靶向疗法对肿瘤生长的潜在预防效果。这项研究支持这样一种观点,即位于结肠腔表面附近的Lgr5 +细胞是结直肠癌的核心。随着进一步发展,本研究在概念上证明的靶向局部Lgr5 +癌症干细胞对于预防高危人群的结肠癌可能是可行的。